September is Ovarian Cancer Awareness Month. To celebrate, we hosted an “Ask the Expert” conversation in our ovarian cancer community. We invited Deb Zajchowski, Ph.D. to join us for a very informative and very collaborate discussion about ovarian cancer recurrence, … Read more
The birth control pill has not only granted women greater reproductive freedom, it may have also protected them against dying from ovarian cancer, suggests a new study published Tuesday in the Annals of Oncology.
Researchers analyzed trends in ovarian cancer … Read more
A clinical trial involving patients with advanced cancers is the first of its kind to show the benefit precision medicine can have on delaying tumour recurrence.
Data from the Paris-based MOSCATO-01 study, presented at the Molecular Analysis for Personalised Therapy … Read more
By: Annette McElhiney
Each of us wears a pair of glasses through the prism of which all things are viewed and interpreted. Having been diagnosed with advanced ovarian cancer in 2008, my glasses are forever skewed by that particular experience.… Read more
By: Ruth D. Merz
As I been reminded repeatedly, “You do know you are past your expiration date, don’t you?” With a Stage 2B and Grade III diagnosis in 2009, and a relapse in 2012, my chances for a normal … Read more
OVARIAN CANCER IS OFTEN MISTAKEN FOR STOMACH PROBLEMS
The early symptoms of ovarian cancer are easily missed, so getting educated is the best thing you can do to protect yourself!
‘Early symptoms of ovarian cancer tend to be subtle. Bloating, … Read more
The Food and Drug Administration on Wednesday warned women and their doctors that current screening tests for ovarian cancer are unreliable and could lead to false diagnoses.
In a statement, the FDA said it was “especially concerned about delaying effective … Read more
It’s important to have regular women’s health exams namely a pelvic exam because it can find some reproductive systems at an early stage. When ovarian cancer is found early at a localized stage, about 94% of patients live longer than … Read more
For most women, the risk of developing ovarian cancer is low – only about 1.3 percent will get that diagnosis in their lifetime, according to the National Cancer Institute. Unfortunately, however, ovarian cancer often isn’t caught at early stages, making … Read more
It is fitting that a Food and Drug Administration alert this week about tests marketed for ovarian cancer screening came out in September, which President Bill Clinton declared in 1998 to be National Ovarian Cancer Awareness Month.
The FDA’s “safety … Read more
As part of the “Ask the Expert” series with our partner Smart Patients, The Clearity Foundation’s Deb Zajchowski will join the ovarian cancer community on SmartPatients.com from Thursday, September 15 at 12:00pm (PST) until 5:00 pm (PST) on Friday, September … Read more
A new class of drugs could be a significant step forward in the treatment of ovarian cancer, one of the most lethal forms of the disease. The drugs, known as PARP inhibitors, are thought to help the body slow the … Read more
Call it luck — or a medical miracle. During clinical trials for experimental cancer drugs, some patients simply respond better than others. And a tiny fraction of patients see dramatic results, responding so well to treatment that they survive forms … Read more
With cancer, there are generally two scenarios – you either have it or you don’t. But I am somewhere in the middle, stuck inside a vortex. I don’t have cancer, but as a notable breast surgeon told me, “For you, … Read more
By: Annette McElhiney
Many factors contribute to ovarian cancer being such a difficult disease both to diagnose and to control. First, unlike breast cancer where mammograms can detect fully contained tumor, no specific test can detect the presence of ovarian … Read more
On Monday, the devastating news broke that screen icon and comedy trailblazer Gene Wilder has passed away. He was 83. Wilder’s nephew Jordan Walker-Pearlman confirmed to Variety that he died due to complications from Alzheimer’s disease. As we pay tribute … Read more
Use of a blood test in the monitoring of ovarian cancer patients who are in remission is an example of the “fatal attraction of more information” in medicine, according to an editorial published July 21 in JAMA Oncology.
The … Read more
When Sherry Pollex was diagnosed with stage three ovarian cancer at age 35, one doctor suggested she wouldn’t live more than a couple of years. But two years later, after beating that prognosis, she celebrated by launching SherryStrong.org — a … Read more
Medical science is more advanced than at any point in history. Yet the health care system — medical science applied to actual patients — still leaves many people without the best and latest treatments.
For example, new knowledge about health … Read more
Buried in the fine print of many marketplace health plan documents is language that allows them to refuse to cover a range of services that are used more often by women, a study finds. It’s unclear if these exclusions have … Read more
